Medical device developer DFine said that two studies presented at this week's Society of Interventional Radiology (SIR) annual meeting in San Francisco strongly support its radiofrequency-targeted vertebral augmentation (RF-TVA) technology for treating vertebral fractures.
In the first study, DFine's StabiliT vertebral augmentation system was judged to be a safe and effective method for treating vertebral compression fractures, DFine said. Lead author Dr. Franklin Moser of Cedars-Sinai Medical Center found that the technology led to a 34% improvement in average Oswestry Disability Index scores (p < 0.0001).
The second study, led by Dr. Bassem Georgy of the University of California, San Diego, found that targeted cement augmentation using the RF-TVA technique may yield up to a 50% reduction in leakage when compared to balloon kyphoplasty and vertebroplasty, even when performed with high-viscosity cement.
